MCRB vs PSA · rev $1.1M vs rev $1.23B
Seres Therapeutics Inc (MCRB) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
PSA (PSA) common stock.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
MCRB currently screens at market cap $109.8M. PSA currently screens at market cap $0.
Not investment advice. Open the MCRB and PSA stock pages for the full models.
Not investment advice.